South Africa had become a global leader in medical research, particularly in HIV and tuberculosis, thanks to years of investment and collaboration. But recent funding cuts by the Trump administration—slashing hundreds of millions in support—have gutted critical programs, leaving labs scrambling and progress in jeopardy. It’s a stark example of how political decisions can unravel years of scientific advancement overnight.

Editor’s Note: This isn’t just about budget lines—it’s about real-world consequences. South Africa’s research was a lifeline for global health, especially in fighting diseases that disproportionately affect poorer countries. The cuts don’t just hurt scientists; they risk rolling back hard-won gains in treating HIV and TB, with ripple effects far beyond borders. When funding vanishes, so does hope for breakthroughs.